结合的FXIII-C3自身抗体引起出血和补充功能障碍在自身免疫性FXIII缺乏症.
Shanshan Luo1, Jun Deng1, Yue Liu2
1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
The Journal of clinical investigation
|December 9, 2025
概括
自身免疫系因子XIII (FXIII) 缺乏症涉及补体功能障碍和自抗体,可以中和FXIII并抑制免疫反应. 这导致对真菌感染的易感性增加,从而形成了FXIII消费的自我放大循环.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 病变的发生和发病.
背景情况:
- 自身免疫XIII因子 (FXIII) 缺乏症是一种罕见的出血性疾病,其发病因子不明.
- 越来越多的FXIII消费与感染有关.
- 严重出血和高死亡率是这种疾病的特征.
研究的目的:
- 为了阐明自身免疫性FXIII缺乏症的发病原因.
- 调查感染,自身抗体生成和补充功能障碍之间的相关性.
- 为了确定潜在的治疗目标.
主要方法:
- 对自身免疫性FXIII缺乏症患者的临床研究.
- 使用小鼠模型进行体内实验.
- 分析组合的FXIII-C3自身抗体及其对FXIII活性和补充通路的影响.
- 对血小板激活和CD40连接体 (CD40L) 释放的评估.
主要成果:
- 患有自身免疫性FXIII缺乏症的患者和小鼠表现出补充功能障碍.
- 病原性感染和自身抗体生成之间存在正相关性.
- 鉴定出结合的FXIII-C3自身抗体,中和FXIII并抑制补充.
- 免疫力受损增加了对Candida albicans感染的易感性.
- 真菌感染引发血小板激活和CD40L释放,促进自身抗体的产生,形成一个自我放大循环.
结论:
- 自免疫性FXIII缺乏症涉及FXIII中和,补充抑制和感染引起的免疫失调之间的复杂相互作用.
- 一个涉及自身抗体,补体功能障碍和机会性感染的自我放大循环驱动着渐进的FXIII消费.
- 这些发现提供了对疾病发病的洞察力,并建议针对自身免疫性FXIII缺乏症的潜在治疗策略.
相关概念视频
Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Extrinsic and Intrinsic Pathways of Hemostasis
11.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.8K
Complement System
9.6K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
9.6K
Clot Retraction and Fibrinolysis
8.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.3K
Inflammatory Bowel Disease I: Ulcerative Colitis
862
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
862


